Nature reviews drug discovery文章索引

期刊目录筛选

期刊名：Nature reviews drug discovery

缩写：NAT REV DRUG DISCOV

ISSN：1474-1776

e-ISSN：1474-1784

IF/分区：101.8/Q1

文章目录更多期刊信息

共收录本刊相关文章索引3955条

FDA new drug approvals in Q3 2025 [0.03%] 2025年第三季度美国食品药品监督管理局新药审批情况

Paul Verdin Paul Verdin

Nature reviews. Drug discovery. 2025 Oct 13. DOI:10.1038/d41573-025-00170-3 2025

Innovation in medicines for global health: a 20-year landscape analysis [0.03%] 全球卫生领域医药创新：二十年分析报告

Paul Ashigbie,Rajiv Shah,Thierry Diagana et al. Paul Ashigbie et al.

Nature reviews. Drug discovery. 2025 Oct 13. DOI:10.1038/d41573-025-00164-1 2025

Cancer cachexia contender enters first pivotal trial [0.03%] 抗癌恶病质新药开展首个关键性试验

Asher Mullard Asher Mullard

Nature reviews. Drug discovery. 2025 Oct 10. DOI:10.1038/d41573-025-00168-x 2025

Roche buys MASH contender for up to US$3.5 billion [0.03%] 罗氏斥资最多35亿美元收购MASH竞争对手

Asher Mullard Asher Mullard

Nature reviews. Drug discovery. 2025 Oct 8. DOI:10.1038/d41573-025-00167-y 2025

Genmab nabs EGFR × LGR5 bispecific in US$8 billion Merus acquisition [0.03%] 艾加特珠单抗EGFR×LGR5双抗权益被金宝收购荷兰Merus公司将获80亿美元收益

Asher Mullard Asher Mullard

Nature reviews. Drug discovery. 2025 Oct 8. DOI:10.1038/d41573-025-00166-z 2025

FDA approves BTK inhibitor for chronic hives [0.03%] FDC批准BTK抑制剂用于慢性荨麻疹

Asher Mullard Asher Mullard

Nature reviews. Drug discovery. 2025 Oct 8. DOI:10.1038/d41573-025-00165-0 2025

Designer peptide retunes channel function [0.03%] 设计肽重新调节通道功能

Katie Kingwell Katie Kingwell

Nature reviews. Drug discovery. 2025 Oct 7. DOI:10.1038/d41573-025-00163-2 2025

Macrocyclic peptides challenge cell cycle defects [0.03%] 大环肽挑战细胞周期缺陷

M Teresa Villanueva M Teresa Villanueva

Nature reviews. Drug discovery. 2025 Oct 7. DOI:10.1038/d41573-025-00162-3 2025

In vivo chimeric antigen receptor (CAR)-T cell therapy [0.03%] 体内嵌合抗原受体(CAR)T细胞疗法

Adrian Bot,Andrew Scharenberg,Kevin Friedman et al. Adrian Bot et al.

Chimeric antigen receptor (CAR)-T cell therapy has transformed the outcomes of patients with haematological malignancies, yet its use is limited by labour-intensive manufacturing, constrained production capacity and variable clinical perfor...

Review Nature reviews. Drug discovery. 2025 Sep 30. DOI:10.1038/s41573-025-01291-5 2025

Designing new antibiotics [0.03%] 新型抗生素的研发

Sarah Crunkhorn Sarah Crunkhorn

Nature reviews. Drug discovery. 2025 Sep 23. DOI:10.1038/d41573-025-00160-5 2025